Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM

NCT02375555 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide
DRUG: Elotuzumab
DRUG: Bortezomib
DRUG: Dexamethasone
PROCEDURE: Stem Cell Mobilization

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]